Post by Bilthoven Biologicals

🚀 Bilthoven Biologicals strongly supports the NL–India strategic partnership 🤝 This week, our CEO Jurgen Kwik joined the panel “Beyond Market Access: Business Opportunities in the New EU–India Era” at the Netherlands India Business Meet 2026, hosted by Netherlands India Chamber of Commerce and Trade (NICCT), at Van der Valk Schiphol. The event opened with inspiring contributions from H.E. Ambassador Kumar Tuhin (Embassy of India to the Netherlands) and H.E. Ambassador Marisa Gerards (Embassy of the Netherlands to India), joining virtually from New Delhi, setting the stage for an engaging dialogue on the future of EU-India collaboration. During the panel, alongside Charbel Moussa, PhD (KPMG) and Michiel Smit (RVO), Jurgen highlighted that mutual trust, shared learning, and continuous innovation are essential to building successful and sustainable cross-border partnerships. Bilthoven Biologicals is a tangible example of what this collaboration can achieve. From our facilities in the #Netherlands our vaccines reach more than 140 countries, driven by the combined strengths of Dutch and Indian expertise in science, manufacturing, and innovation. Together, we are advancing global access to life-saving vaccines. Thank you to Netherlands India Chamber of Commerce and Trade for bringing together leaders from government, business, and policy to shape the next chapter of EU–India cooperation 🌍 #BilthovenBiologicals #India #Netherlands #Indo-Dutch #Vaccines #GlobalHealth #Vaccinemanufacturing #pharmaceuticals